← Browse by Condition
Medical Condition

non muscle invasive bladder neoplasms

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06833073 Phase 2
Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Enrollment
308 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →